Trust me, I'm a scientist: Will urologists set a lead for geneticists to follow?

Lancet

Volumn 347, Issue 9005, 1996, Pages 883-884

  Raffle, A E ^a  

^a Avon Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY DIAGNOSIS; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; INFORMED CONSENT; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; UROLOGY; ARTICLE; DIAGNOSTIC TEST; FEMALE; GENETIC SCREENING; GENETICS AND REPRODUCTION; HEALTH CARE AND PUBLIC HEALTH; MASS SCREENING; MEDICAL ETHICS; METHODOLOGY; NATURAL SCIENCE; PROSTATE TUMOR; TIME; UNITED KINGDOM; UTILIZATION REVIEW;

PROSTATE SPECIFIC ANTIGEN;

GENETICS AND REPRODUCTION; HEALTH CARE AND PUBLIC HEALTH; NATURE;

DIAGNOSTIC TESTS, ROUTINE; ETHICS, MEDICAL; FEMALE; GENETIC SCREENING; GREAT BRITAIN; HUMANS; INFORMED CONSENT; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RESEARCH DESIGN; TIME FACTORS;

EID: 0029944576     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91353-7     Document Type: Article

References (13)

1. When is genetic screening permissible. Nature 1995; 337: 273.
2. Mant D. Prevention. Lancet 1994; 344: 1343-46.
3. Murphy SB, Cohn SL, Craft AW, et al. Do children benefit from mass screening for neuroblastoma? Consensus statement from the American Cancer Society Workshop on Neuroblastoma Screening. Lancet 1991; 337: 344-46.
4. Knox EG. Case-control studies of screening procedures. Public Health 1991; 105: 55-61.
5. Knox EG. Cancer of the uterine cervix in trends in cancer incidence. London. Hemisphere, 1982.
6. Miller AB. Evaluation of the impact of screening for cervical cancer. In: Hakama M, Miller AB, Day NE, eds. Screening for cancer of the uterine cervix. IARC Scientific Publications No 76. IARC Lyons, 1986.
7. Wilson JMG, Jungner G. Principles and practice of screening for disease. Public Health Papers No. 34. World Health Organization, 1968.
8. Harper PS. Genetic testing, common diseases, and health service provision. Lancet 1995; 346: 1645-46.
9. Imperial Cancer Research Fund OXCHECK Study Group Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ 1994; 308: 308-12.
10. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of the British family heart study. BMJ 1994; 308: 313-20.
11. Davey Smith G, Song F, Sheldon T. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993; 306: 1367-73.
12. Stroud E, et al. Blood cholesterol testing, the cost effectiveness of opportunistic cholesterol testing. Report by the Standing Medical Advisory Committee to the Secretary of State for Health. May 1990.
13. Davey Smith G, Sheldon T. Consensus conferences as drug promotion. Lancet 1993; 341: 100-02.